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SLI-1, a Caenorhabditis elegans homologue of the proto-oncogene product c-Cbl, is a negative
regulator of LET-23-mediated vulval differentiation. Lack of SLI-1 activity can compensate for
decreased function of the LET-23 epidermal growth factor receptor, the SEM-5 adaptor, but not
the LET-60 RAS, suggesting that SLI-1 acts before RAS activation. SLI-1 and c-Cbl comprise an
N-terminal region (termed SLI-1:N/Cbl-N, containing a four-helix bundle, an EF hand calcium-
binding domain, and a divergent SH2 domain) followed by a RING finger domain and a
proline-rich C-terminus. In a transgenic functional assay, the proline-rich C-terminal domain is
not essential for sli-1(1) function. A protein lacking the SH2 and RING finger domains has no
activity, but a chimeric protein with the SH2 and RING finger domains of SLI-1 replaced by the
equivalent domains of c-Cbl has activity. The RING finger domain of c-Cbl has been shown
recently to enhance ubiquitination of active RTKs by acting as an E3 ubiquitin–protein ligase. We
find that the RING finger domain of SLI-1 is partially dispensable. Further, we identify an
inhibitory tyrosine of LET-23 requiring sli-1(1) for its effects: removal of this tyrosine closely
mimics the loss of sli-1 but not of another negative regulator, ark-1. Thus, we suggest that this
inhibitory tyrosine mediates its effects through SLI-1, which in turn inhibits signaling upstream of
LET-60 RAS in a manner not wholly dependent on the ubiquitin–ligase domain.
INTRODUCTION
Receptor tyrosine kinase (RTK)/Ras/MAPK signaling path-
ways are functionally conserved among metazoans in vari-
ous aspects of cell growth and differentiation (Schlessinger
and Ullrich, 1992; Fantl et al., 1993). Because unregulated
RTK signaling can promote abnormal cell growth or differ-
entiation, precise control of both the duration and the level
of RTK activation is important (Cantley et al., 1991; Ro-
drigues and Park, 1994), and thus it is crucial to understand
the negative regulation of RTK signaling.
RTK-mediated signal transduction is initiated by ligand
binding, dimerization, and subsequent autophosphorylation
of cytoplasmic tyrosines within the C-terminal of the recep-
tor (Ullrich and Schlessinger, 1990; Fantl et al., 1993; Claes-
son-Welsh, 1994). Phosphotyrosine (pTyr) sites in activated
RTKs recruit the Grb2/SEM-5/Drk adaptor protein (Clark et
al., 1992a; Lowenstein et al., 1992; Oliver et al., 1993; Simon et
al., 1993). This adaptor protein is associated with the Sos
guanine nucleotide exchange factor (Egan et al., 1993; Gale et
al., 1993; Li et al., 1993). Once recruited to the membrane, Sos
activates the membrane-bound Ras protein by enhancing the
exchange of GTP for GDP (Simon et al., 1991; Gale et al., 1993;
Li et al., 1993; Rozakis-adcock et al., 1993; Aronheim et al.,
1994; Quilliam et al., 1994). Activated Ras recruits the Raf
serine/threonine kinase to the membrane, where Raf is ac-
tivated by unknown mechanisms (Campbell et al., 1998;
Rommel and Hafen, 1998). Raf phosphorylates and activates
MAPK kinase (MEK), which in turn phosphorylates and
activates MAPK (Dent et al., 1992; Howe et al., 1992; Kyriakis
et al., 1992; Tsuda et al., 1993), leading to diverse cellular
responses. The development of the Caenorhabditis elegans
vulva provides a readily accessible genetic system for the
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study of RTK signaling and regulation in vivo (Sundaram
and Han, 1996; Kornfeld, 1997; Sternberg and Han, 1998;
Chang and Sternberg, 1999). The wild-type vulva is derived
from precisely three of six multipotential vulval precursor
cells (VPCs) that generate vulval tissue when induced by the
gonadal anchor cell (Horvitz and Sternberg, 1991). The in-
duced VPCs undergo three rounds of division and a char-
acteristic morphogenesis to form the vulva. VPCs that do
not receive adequate signal from the anchor cell divide only
once and become part of the hyp7 syncytial epidermis. The
LIN-3 protein has a single epidermal growth factor (EGF)
domain and is produced by the anchor cell (Hill and Stern-
berg, 1992). LET-23, a homologue of the EGF receptor
(EGFR) and likely receptor for LIN-3, is necessary not only
for vulval differentiation but also for other aspects of devel-
opment (Aroian et al., 1990; Aroian and Sternberg, 1991;
Clandinin et al., 1998; Jiang and Sternberg, 1998; Chang et al.,
1999). LET-23 activation initiates a signaling cascade that
involves SEM-5 (Grb2), LET-341 SOS-1 (Sos), LET-60 (Ras),
LIN-45 (Raf), MEK-2 (MAPK/ERK kinase), and MPK-1
(MAP kinase) (Chang et al., 2000; Clark et al., 1992b; Han et
al., 1990; Han et al., 1993; Kornfeld et al., 1995; Lackner et al.,
1994; Wu and Han, 1994; Wu et al., 1995). Reduction-of-
function (rf) mutations in any of the signaling proteins in the
LET-23 RTK pathway result in less than three VPCs under-
going vulval differentiation. In the most severe cases, the
disruption of the LET-23-mediated signaling results in the
complete failure to generate vulval tissue (vulvaless, or Vul,
phenotype). In contrast, an abnormal increase in signaling
due to activating mutations in the pathway or the removal of
two or more negative regulators of the pathway causes the
opposite effect in which greater than wild-type numbers of
VPCs differentiate into vulval tissue (multivulva, or Muv,
phenotype).
The sli-1 locus was identified in a screen for suppressors of
the Vul phenotype associated with let-23(rf) mutations
(Jongeward et al., 1995). sli-1 encodes proteins of 582 and 540
amino acids that are similar to the mammalian proto-onco-
gene products c-Cbl, Cbl-b, and Cbl-3 (Langdon et al., 1989;
Keane et al., 1995; Keane et al., 1999). SLI-1 and c-Cbl proteins
are composed of an N-terminal region, followed by a RING
finger domain and a proline-rich C-terminus (see Figure 3).
The N-terminal region (termed SLI-1:N/Cbl-N) contains the
following three interacting domains: a four-helix bundle; an
EF hand; and a divergent SH2 domain (Meng et al., 1999).
Genetic analysis has revealed that sli-1 is a negative regula-
tor of those let-23 signaling functions that are mediated
through RAS activation (Jongeward et al., 1995). Mice lack-
ing c-Cbl have inappropriate ZAP-70 activity in T cells,
indicating that c-Cbl plays a negative role in signaling (Mur-
phy et al., 1998). Experiments performed in vitro suggest that
c-Cbl directly controls down-regulation of RTKs. This is
dependent on the SH2 domain, which mediates binding to
activated receptor followed by phosphorylation of c-Cbl at a
site adjacent to the RING finger domain. The RING finger
domain then is essential for the last step of catalyzing recep-
tor ubquitination (Levkowitz et al., 1998; Joazeiro et al., 1999;
Levkowitz et al., 1999).
Here we show that c-Cbl and SLI-1 are functionally equiv-
alent. Genetic analysis reveals that SLI-1 acts to negatively
regulate EGFR signaling upstream of LET-60 RAS, either at
the receptor or Grb2/SEM-5 step. We compare sli-1 function
to that of other negative regulators of this pathway, gap-1
(Hajnal et al., 1997) and ark-1 (Hopper et al., 2000). We
provide evidence that SLI-1 inhibition is partly mediated
through an inhibitory tyrosine in the carboxy terminus of
the LET-23 EGFR, and, in contrast to the ubiquitin ligase
activity, this inhibition is not wholly dependent on the RING
finger of SLI-1.
MATERIALS AND METHODS
Strain Construction and Maintenance
Strains were maintained at 20°C and handled according to the
method of Brenner (1974). The following alleles were used for strain
construction: for LGI, unc-38(x20); LGII, dpy-10(e128), let-23(sy1,
sy97), unc-4(e120), clr-1(e1745); for LGIV, unc-24(e138), dpy-20(e1282),
ark-1(sy247), let-60(sy127, n1876, n2021, n2022, n2034, n2035) (Beitel
et al. 1990; Han et al. 1990); and for LGX, sli-1(sy143), sem-5(n1619,
ay73), gap-1(n1691), unc-2(e55) (Clark et al. 1992a; M. Stern, personal
communication). szT1 is a reciprocal I;X translocation that is used as
a balancer for SEM-5 (Fodor and Deak, 1985). DnT1 is a reciprocal
IV;V translocation that is used as a balancer for let-60 (Ferguson and
Horvitz, 1985). sDf8 is a small deficiency in LGIV that uncovers
let-60 (Rogalski et al., 1982).
sli-1 sem-5 double mutants were constructed in the following
manner: for sli-1 sem-5(n1619), N2 males were mated into unc-4; sli-1
hermaphrodites. Non-Unc male progeny were selected and mated
into clr-1(e1745); sem-5(n1619) hermaphrodites. Non-Egl (egg-laying
positive) healthy progeny were picked singly onto individual plates
and checked for non-Clr Unc Egl progeny. These non-Clr Unc Egl
progeny were again picked singly on to individual plates. If sli-1
suppressed SEM-5, then only those recombinants of the genotype
unc-4; sli-1 sem-5(n1619)/1 sem-5(n1619) would survive to give F2
progeny, because sem-5(n1619) homozygotes do not propagate be-
yond F1 from heterozygous mothers. Otherwise, no Unc Egl prog-
eny would survive (except the small number of cases in which there
was a clr-1 unc-4 recombinant chromosome; these were selected
against by checking for the lack of a Clr phenotype). unc-4 was
removed from sli-1 sem-5(n1619) by mating N2 males and selecting
non-Unc F1 progeny. Non-Unc, sickly, slow-growing progeny were
individually isolated in F2 and again in F3 and were checked for
non-Unc F4 progeny. For the construction of sli-1 sem-5(ay73), N2
males were mated into sli-1 hermaphrodites. The resulting male
progeny were mated into unc-38(x20)/szT1; sem-5(ay73)/szT1 her-
maphrodites. Many healthy progeny were picked singly on to in-
dividual plates from this cross. F2 notch-heads (an indication of the
presence of sli-1 then were picked singly from only those F1 plates
that did not segregate phenotypically long males (szT1 segregates
lon-2 males). The notch-head F29s could be categorized into three
classes depending on their F3 progeny. The first class yielded only
healthy progeny (F2 homozygous for sli-1). The second class yielded
healthy progeny, no dead larvae, no dead eggs, and many Egl
animals with dead larvae or dead eggs inside (sli-1 almost com-
pletely suppresses the F1 lethality caused by sem-5(ay73) mutation).
These F2s were likely to be sli-1 sem-5(ay73)/sli-11 recombinants.
The third class produced no progeny and were Egl by themselves.
This final class of F2s were sli-1 sem-5(ay73). Since the sli-1 SEM-
5(ay73) strain cannot be maintained as homozygotes, szT1 was used
to balance sli-1 sem-5(ay73). The presence of sli-1 mutations in Egl
animals was further confirmed by sequencing.
To construct sli-1 gap-1 double mutants, sli-1 males were mated
into gap-1 unc-2 hermaphrodites. Non-Unc cross-progeny were in-
dividually isolated and checked for Unc progeny. These Unc prog-
eny then were picked singly. Only those recombinants of the geno-
type sli-1 gap-1 unc-2/1 gap-1 unc-2 can segregate Muv progeny if
sli-1 and gap-1 synergize to confer the excessive vulval differentia-
tion. On rare plates, Muv progeny were observed and picked singly
in the next generation. In their progeny, the low penetrance of
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notch-head phenotype was used to confirm the presence of sli-1
mutation.
The let-60; sli-1 strains were constructed as follows: N2 males
were mated into unc-24(e138) let-60(rf or null)/DnT1; 1/DnT1 strains.
let-60(rf) alleles used were mentioned above. Non-Unc cross-prog-
eny males were selected and mated into dpy-20; sli-1 hermaphro-
dites. Non-Dpy cross-progeny males then were picked and mated
into dpy-20; sli-1. Non-Dpy hermaphrodites were then picked sin-
gly. From those F1 plates that yielded Unc progeny, Unc non-Dpy
and non-Unc non-Dpy progeny were individually isolated. Since
sli-1 did not suppress let-60 lethality, nonrecombinant Unc non-Dpy
progeny did not survive past F1. The strains were maintained as
non-Unc non-Dpy heterozygotes of the following genotype: unc-
24(e138) let-60(rf or null) 1/1 1 dpy-20; sli-1. F1 Unc non-Dpy
progeny then were picked singly and scored for vulval differentia-
tion. Each scored worm was recovered from the slide and allowed
to propagate to check for F2 progeny. Vulval differentiation scores
from those that gave viable F2 progeny yielding a proportion of Dpy
animals were discarded as they represented recombinants that were
not homozygous for let-60.
To construct the heteroallelic series, the strain dpy-10(e128); unc-
24(e138) let-60(n2021)/DnT1; 1/DnT1 was made by standard meth-
ods. let-60(n2021) is a weak rf allele. To generate the various het-
eroallelic worms, N2 males were mated into the unc-24(e138) let-
60(rf or null)/DnT1; 1/DnT1 strains carrying the different severe
let-60 mutations. Non-Unc cross-progeny males were selected and
mated into the dpy-10(e128); unc-24(e138)let-60(n2021)/DnT1;
1/DnT1 strain. Unc-24, non-Dpy, non-DnT1 F1 hermaphrodites
from these crosses were scored for vulval differentiation. Scored
worms were recovered, and their progeny were checked to ensure
that let-60(rf or null) remained homozygous.
Other strains were constructed following standard methods.
An In Vivo Transgenic Assay for the Activity of
sli-1 Minigenes
To establish a system in which to study the relationship between
SLI-1 structure and its function, we constructed sli-1 cDNA mini-
gene constructs driven by the heat shock promoter hsp16–41
(Stringham et al., 1992; Mello and Fire, 1995). To facilitate expres-
sion, an artificial intron is present between the promoter and the
cDNA insert. Heat shock promoters were used in these experiments
because the initial tests using genomic sequences 59 to the start
codon of sli-1 fused to the full-length sli-1 cDNA failed to confer
significant wild-type SLI-1(1) activity in the vulva (our unpub-
lished results), presumably because sequences present within the
introns of sli-1 are necessary for expression.
Germline transformation was performed according to the meth-
ods of Mello et al. (1991). Heat-shock constructs were injected at 50
ng/ml along with 150 ng/ml SK1 plasmid and 15 ng/ml pMH86
(dpy-20(1) marker) into the germline of let-23(sy1); dpy-20; sli-1
animals. Independent non-Dpy transformant lines were maintained
and selected for transgene stability. F3 stable transgenic progeny
were selected for egg-lay cohorts and heat shock analysis. For the
egg-lay cohorts, we selected only those worms with a egg-laying
rate similar to that of wild-type hermaphrodites (;5–10 eggs laid
per worm per hour).
Thirty egg-laying young hermaphrodites were moved onto fresh
agar plates, 10 worms per plate. These then were allowed to lay eggs
on given plates for 1 h before being moved to fresh plates. The
hourly transfer of worms was continued for 6 consecutive hours,
and the egg-laying hermaphrodites then were removed from the
plates. The plates were maintained at 20°C during and after the
establishment of the egg cohorts. 36 h after the hermaphrodites’
removal from the final cohort of eggs, the plates were heat shocked
for 30 min at 33°C. Thus, we generated worms synchronized in age
into hourly cohorts that had been heat shocked between 36 and 42 h
after egg laying. This interval encompasses the early L3 stage dur-
ing which vulval induction occurs in the transgenic animals. The
heat-shocked plates were returned to 20°C for 18–24 h after heat
shock.
Vulval differentiation was scored in non-Dpy progeny at early to
mid L4 stages. A minimum of two independent lines was scored per
heat shock construct. Fifteen to 30 worms were scored per 1-h time
interval per stable line after heat shock. The distributions generated
from each heat shock construct (as seen in the histograms of Figure
4B) were compared in pairs using the Mann-Whitney test to gener-
ate two-tailed p values. There is approximately a two-cell range in
the average induction levels between the no-insert control and the
full-length sli-1 cDNA construct. This range allows comparisons of
the various induction levels in different minigene constructs. In the
structure–function experiments, SLI-1 activity is inferred in those
minigene constructs that lower average vulval differentiation to
significantly ,2.5 vulval cells per worm.
sli-1 Minigenes and Mutagenized let-23 Constructs
Site-directed in vitro mutagenesis was carried out in double-
stranded DNA according to the method prescribed by Deng and
Nickoloff (1992) and with reagents and specific protocols from
Clonetech (Palo Alto, CA). The mutagenesis was carried out in the
plasmid pCY-D6, a pSK1 vector containing the full-length sli-1
cDNA inserted into the EcoRI site. A selection primer that changed
the novel NotI site in the vector to an NheI site was used in conjuc-
tion with mutagenic primers that mutated or removed sequences of
varying length within the sli-1 coding region. Mutagenized sli-1
cDNA then was digested with SpeI/EcoRV and was inserted into the
NheI/EcoRV sites of the pPD49.83 and pPD49.78 nematode heat
shock minigene vectors. Mutagenesis was confirmed by restriction
mapping and by sequencing. The deletion constructs SLI-
1.DNDRINGDC, SLI-1.DC, SLI-1.DNDRING, SLI-1.DPro2, and SLI-
1.DPro3 replace the deleted sequences with an NheI site that codes
for alanine and serine in frame with the remainder of the sli-1
construct. Primers used for in vitro mutagenesis of the sli-1 cDNA
are as follows: SKNotNhe; Del-NC(Nhe); Del-C(Nhe); Del-N(Nhe);
Altspli; Del-PRO2(Nhe); Del-PRO3(Nhe); Del-RING.
For the deletion of the putative myristylation site, we utilized a
selection primer which changed a unique XhoI site into a ClaI site in
the various mutagenized sli-1 cDNAs. Primers used were SKXhoCla
and Del-MYR1. The cloning into heat shock vectors followed iden-
tical procedures as above.
The conserved N-terminal domain of human c-Cbl was PCR
amplified from the cDNA in a pUC vector (provided by W. Lang-
don) using the primers hCbl-N1A(Nhe) and hCbl-N2R(Nhe). The
ends of the amplification primers contained in-frame NheI sites. The
amplified conserved N-terminal fragment of c-Cbl then was puri-
fied, digested, and ligated into the NheI site of the SLI-1.DN con-
struct in pPD49.83. The directionality of the insert was checked by
restriction digests, and the sequence of the amplified c-Cbl fragment
was verified by DNA sequencing. DNA sequencing was carried out
on automated sequencers (Applied Biosystems, Foster City, CA) by
the California Insitute of Technology DNA Sequencing Facility.
All the systematically mutagenized let-23 constructs were made
as described by Lesa and Sternberg (1997). Engineered let-23 con-
structs were injected into the germline of let-23(sy17)unc-4/mnc1;
dpy-20; sli-1 or let-23(sy17)unc-4/mnc1; dpy-20 ark-1 mothers; the
Unc-4, non-Dpy stable transformed progeny (F2 or later generation)
were tested for effects in vulval differentiation.
Primer Designations
Primer names and their corresponding sequences used during in
vitro mutagenesis are as follows:
SKNotNhe:59- ACCGCGGTGGCTAGCGCTCTAGAAC
Del-NC(Nhe):59- GCCCGGTTTCTGCAGTGAAGAGGCTAGCT-
AGACTTGTGTAAATGTTCATCTTACC
Del-C(Nhe):59- GTGTGATTATTGACAGGTTCAAGCCCGCTA-
GCTAGACTTGTGTAAATGTTCATCTTACCG
Multiple Domains of SLI-1
Vol. 11, November 2000 4021
Del-N(Nhe):59- GATGCCCGGTTTCTGCAGTGAAGAGGCTAG-
CACTCCGGTAGAAATTGAAAAAGCG
Altspli:59- CCCGACGTGCCTCCCAGAACGTCGTCACAAACA-
TCCTCTTCATACG
Del-PRO2(Nhe):59- CTCAATTCCGTCGGTCGACGAGGCTAG-
CGCATTGGGTACCCTGGACAC
Del-PRO3(Nhe):59- GGCACAAGTGGTAAACCGGCAACGGGC-
TAGCTCAGCGAGCGAGCACCAACCACACC
DEL-RING:59- TTGTGAGATGGGCACAACATTCGAGTACGA-
AATCAAAGGAACAAATCGTGT
SKXhoCla:59- ACCGTCGACATCGATGGGGGGCCCG
Del-MYR1:59- GTTTCACCGGGAATGGCTAGCATAAACACA-
ATTTTTC
hCbl-N2R(Nhe):59- GCCACTGCTAGCAGGATCAAACGGATC-
TACCAC
hCbl-N1A(Nhe):59- CCGCCGGGGGCTAGCGACAAGAAGAT-
GGTGGAG
Microscopy
The extent of vulval differentiation was measured by examining
vulval anatomy in early-to-mid-L4-stage animals (Han et al., 1990).
Hermaphrodites were placed on 5% Noble Agar pads and were
scored with a Plan 100x objective, Nomarski differential interfer-
ence-contrast optics. Vulval fates of 1° and 2° were scored as vulval
cells. Wild-type was equal to three VPCs undergoing vulval differ-
entiation per worm, which equaled 100% vulval differentiation.
RESULTS
sli-1(lf) Suppresses a Severe rf Allele but Not a Null
Allele of SEM-5
Mutations in SEM-5 result in a partial or complete lack of a
vulva. SEM-5 encodes an SH3-SH2-SH3 domain containing
the Grb2 homologue, which is required to transduce the
signal from LET-23 to LET-60 Ras (Clark et al., 1992a, 1992b;
Stern et al., 1993; Katz et al., 1996; Lesa and Sternberg, 1997).
SEM-5(ay73) is an early missense mutation, Q10amber (Q at
codon 10 mutated into an amber stop), that removes all of
the functional domains of the SEM-5 protein and is, there-
fore, a putative null allele (M. Stern, personal communica-
tion). Animals homozygous for ay73 are inviable in the F2
generation, with F1 escapers (due to maternal rescue) being
completely vulvaless (Table 1). The sem-5(n1619) allele gen-
erates a P49L substitution, which most likely results in a
nonfunctional N-terminal SH3 domain (Clark et al., 1992a).
Animals homozygous for n1619 are also inviable in the F2,
and viable F1 animals have, on average, only 0.4 vulval cells
induced per animal. In wild-type animals, three cells are
invariably induced to form the vulva.
We constructed sli-1 sem-5 double mutants using the sli-1
reference allele, sy143. The molecular lesion associated with
sy143 is Q152amber, which removes the carboxyl-terminal
75% of the SLI-1 protein. In addition, it is the most severe
allele and likely generates a nonfunctional product
(Jongeward et al., 1995; Yoon et al., 1995). sli-1 strongly
suppresses the vulval defect in sem-5(n1619) mutants: sli-1
SEM-5(n1619) have near wild-type levels of vulval differen-
tiation (average, 3.0 vulval cells per worm; not all animals
have wild-type level of vulval induction; Table 1, Figure 2D).
The lethality of the sem-5(n1619) allele is also partially sup-
pressed: double mutants can be maintained as homozygotes.
In contrast, sli-1 does not suppress the sem-5(ay73) null allele:
sli-1 sem-5(ay73) double mutants are Vul when scored as F1
homozygotes and cannot be maintained as homozygotes be-
yond F2 from heterozygous mothers (Table 1, Figure 2F). How-
ever, there is increased survival of sli-1 sem-5(ay73) F1 homozy-
gotes from heterozygous mothers in comparison with sem-
Figure 1. Models for negative regulation of LET-23 EGFR signal-
ing by SLI-1. The interpretation is based on our molecular genetic
analyses presented here or on biochemical assays of others pre-
sented in other model systems. LIN-3 binding to the extracellular
domain induces LET-23 dimerization and autophosphorylation of
tyrosine residues that are located in its C-terminal region (C), in-
cluding Y2. The latter targets for the SH2 domain of SLI-1. Local-
ization of SLI-1 to the active receptor presumably enables RING
finger (RF) domain to recognize the substrates and promote their
ligation to ubiquitin via E2 molecule, marking active receptor for
degradation. The recruitment of SLI-1 to the active receptor might
be helped by the binding of the SEM-5 to the receptor Yx sites. The
interaction between SLI-1 and SEM-5, which is mediated by the
proline-rich domain of SLI-1 and the SH3 domain of SEM-5, might
interfere with the localization of LET-341 to the cell membrane by
SEM-5. Yx represents the docking sites in LET-23 for SEM-5.
Table 1. sli-1 suppression of mutations in let-23, sem-5, and let-60a
Genotype
Average no. of VPCs undergoing vulval
differentiation
sli-1(1) sli-1(sy143)
1 3.0 (many animals) 3.0 (n 5 20)b
let-23(sy1) 0.8 (n 5 29)b 4.3 (n 5 30)
let-23(sy97) 0.0 (n 5 20)b 2.9 (n 5 131)
sem-5(n2019) 0.5 (n 5 20)b 2.6 (n 5 23)b
sem-5(n1619) 0.4 (n 5 40) 3.0 (n 5 84)
sem-5(ay73) 0.0 (n 5 20) 0.02 (n 5 23)
gap-1(n1691) 3.0 (n 5 21) 3.2 (n 5 24)
let-60(n1876) 0.0 (n 5 62) 0.08 (n 5 80)
let-60(n2034) 0.02 (n 5 62) 0.03 (n 5 87)
let-60(n2035) 0.05 (n 5 66) 0.09 (n 5 81)
a Extent of vulval differentiation in let-23, sem-5, gap-1, and let-60
mutants in sli-1(1) and sli-1(sy143) backgrounds. The number val-
ues represent the average number of VPCs undergoing vulval dif-
ferentiation per worm (3.0 is wild-type level).
b Data from Jongeward et al. (1995).
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5(ay73) single-mutant F1 homozygotes. Thus, mutations in sli-1
can enhance maternal rescue of lethality associated with sem-5,
which is consistent with the absence of sli-1 compensating for
a reduction in sem-5 activity.
sli-1(lf) Does Not Suppress Severe rf Alleles of let-60
We tested three let-60 alleles for suppression by sli-1. These
let-60 alleles, n1876 (Ala66Thr), n2034 (Ala66Thr), and n2035
(Ala66Val), are described by Beitel et al. (1990). Correspond-
ing mutations have been made in Ha-Ras and have been
shown to interfere with exchange factor interaction (Howe
and Marshall, 1993; Boriack-Sjodin et al., 1998). We find that
sli-1 fails to suppress the vulvaless phenotype of these alleles
(Table 1). In addition, sli-1 also fails to suppress the lethality
associated with these three let-60 alleles. However, as in the
case with sem-5(ay73), there is an increase in F1 homozygote
survival from let-60(rf)/1 heterozygous parents in a sli-1
background, indicating enhanced maternal rescue of lethal-
ity (our unpublished results).
sli-1 fails to suppress null alleles of let-23 and sem-5, while
it strongly suppresses severe rf alleles of let-23 and sem-5
(Jongeward et al., 1995; this study). It was therefore crucial to
determine whether the tested let-60 alleles, n1876, n2034 and
n2035, were non-null alleles. To distinguish between severe
non-null alleles and null let-60 alleles, we measured the
extent of vulval differentiation in a series of F1 trans-het-
eroallelic animals using a weak rf let-60 allele (n2021), in
trans to the three let-60 alleles (n1876, n2034, and n2035), as
well as a putative let-60 null allele (sy127) and sDf8, a defi-
ciency that uncovers the let-60 locus as controls. let-60(n2021)
is also an exchange factor defective mutant (G75S) (Howe
and Marshall, 1993). If n1876, n2034, and n2035 are non-null
mutations then in trans to let-60(n2021) should be less severe
Figure 2. Nomarski micrographs of vulval induction in various genetic backgrounds: (A) wild-type; (B) sli-1(sy143); (C)
sem-5(n1619); (D) sli-1(sy143) sem-5(n1619); (E) sem-5(ay73); and (F) sli-1(sy143) sem-5(ay73). A, B, and D have phenotypically
wild-type vulvae. C, E, and F are phenotypically Vul, where all VPCs have generated epidermal progeny (note the lack of
vulval openings in these panels). In all panels, anterior is to the left and dorsal is toward the top. The scale bar is 20 mm.
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than let-60(null)/let-60(n2021) heterozygote controls in a vul-
val induction assay. In these experiments, n2035 and n1876
had significantly more activity than the sy127 null allele and
the sDf8 deficiency in the vulva (1.6 and 1.4 cells versus 0.8
and 0.6 cells being induced on average [n . 22]). Therefore,
n1876 and n2035 are likely to be rf alleles. Thus, sli-1(rf) fails
to suppress non-null let-60(rf) mutations in the vulva. Since
a lack of sli-1 activity can compensate for the decreased
function of let-23 and SEM-5, but not let-60, we conclude that
SLI-1 acts upstream of RAS activation.
Mutations in sli-1 Give a Muv Phenotype in a gap-1
Mutant Background
GAP-1 is a negative regulator of vulval signaling that likely
acts at the level of LET-60 Ras (Hajnal et al., 1997). A gap-1(lf)
reference allele suppresses the Vul phenotype of let-
60(n1876) while only weakly suppressing the sem-5(n2019)
mutation (Hajnal et al., 1997). As is the case with sli-1 single
mutants, gap-1 mutations by themselves are silent.
We constructed sli-1 gap-1 double mutants. This strain has
a partially penetrant Muv phenotype, with 7 of 24 observed
double mutants exhibiting an excessive vulval induction
(Table 1). gap-1 corresponds to a Q149ochre nonsense mu-
tation, which results in early truncation and presumably
defines a null allele (Hajnal et al., 1997). The simplest inter-
pretation of this result is that SLI-1 and GAP-1 have, at least
partially, distinct activities.
The Conserved N-terminal Region and RING Finger
Domain Rather Than the Proline-rich C-terminal
Region Is Sufficient for the Inhibitory Function of
SLI-1
We established an in vivo transgenic assay for the activity of
sli-1 minigenes being expressed from the hsp16–41 heat-
shock promoter in the genetic background of let-23(sy1); sli-1
(see MATERIALS AND METHODS). The vulvaless pheno-
type of let-23(sy1) animals is strongly suppressed by sli-1
(see Table 1). In control transgenic animals of genotype
let-23(sy1); dpy-20; sli-1; syEx[dpy-20(1); hsp16–41] that
were heat shocked at the time of vulval induction, the av-
erage vulval induction is 2.5 cells per worm (Figure 4).
Under the same experimental conditions and genetic back-
ground, the full-length sli-1 cDNA driven by the hsp16–41
promoter confers full SLI-1(1) activity with animals having,
on average, 0.5 VPCs executing a vulval fate per worm
(henceforth referred to as vulval cells per worm; Figure 4).
This is a full two cells lower than the vulval induction seen
in the no-insert control and is comparable to the levels of
vulval differentiation seen in let-23(sy1) single mutants in a
non-Dpy-20 germline-transformed background (0.3 vulval
cells per worm) (Yoon et al., 1995).
In this transgenic assay, SLI-1 proteins lacking either the
second or third proline-rich domain retained full activity
(average induction, 0.7 and 0.3 vulval cells per animal, re-
spectively; p 5 0.14 and 0.39, respectively). Likewise, the
expression of the alternatively spliced sli-1 cDNA, which
deletes the 10th exon of the genomic sequence, has activity
similar to that of full-length SLI-1 (average, 0.9 vulval cells
per worm; p 5 0.05; Figure 4A). Moreover, we found that
expression of a SLI-1 protein truncated after residue 447, and
thus lacking the entire proline-rich C-terminal domains, also
retains significant SLI-1(1) activity (average, 1.0 vulval cells
per worm; p , 0.0001 versus no-insert control; Figure 4, A
and B). However, this level of activity is also significantly
weaker than that of the full-length sli-1 cDNA (p 5 0.0002).
To test whether proline-rich C-terminal domains are par-
tially sufficient for SLI-1 function, a sli-1 construct lacking
the N-terminal region and RING finger domain (deleting
residues 58 to 447) was tested; it does not have SLI-1(1)
activity under identical assay conditions (vulval induction
levels similar to the no-insert control; p 5 0.8; Figure 4A, B).
Consensus Myristylation Site Is Not Required for
SLI-1(1) Activity
In the conceptual translation of SLI-1, the initiator methio-
nine is followed in sequence by Gly-Ser-Ile-Asn-Thr, a myri-
stylation site (reviewed by Resh 1994). Myristylation may
play a role in localizing proteins to the cell membrane,
usually in combination with other lipid modifications or
nearby basic residues (Resh, 1994). Using site-directed mu-
tagenesis, we substituted the second codon glycine with
alanine (G2A substitution); alanine should maintain the
charge-neutral hydrophobic character of glycine but should
prevent the covalent addition of myristate at the second
codon. Constructs expressing the full-length and truncated
SLI-1 proteins with G2A substitutions do not have less ac-
tivity than control constructs (Figure 4A; p . 0.2). In addi-
tion, the SLI-1 construct that lacks the N-terminal conserved
SH2 and RING finger domains has no activity in the vulva
after the G2A substitution (Figure 4A). As mentioned pre-
viously, the first ;50 amino acid residues of c-Cbl are highly
divergent in sequence from those of SLI-1, and the consen-
sus myristylation sequence is not conserved in c-Cbl, Cbl-b
or Cbl-3.
The Conserved N-terminal Region of c-Cbl
Containing the SH2 and RING Finger Domains Can
Functionally Replace that of SLI-1
The human c-Cbl protein is 906 amino acid residues in
length. The ;400 amino acid stretch of high sequence sim-
ilarity (;55% identity) between c-Cbl and SLI-1 begins after
Figure 3. Schematic alignment of SLI-1 and human c-Cbl. Con-
served domains between the two proteins have been marked in the
same manner. Residues 58–447 of SLI-1 share 55% amino acid
sequence identity to residues 45–437 of human c-Cbl. The four-helix
bundle (4H), EF hand, SH2 domain, the RING finger, and the
putative SH3-binding polyproline domains are indicated. An arrow
marks the C-terminal truncation point of v-Cbl. The figure is a
modified version from Yoon et al. 1995 and Meng et al. 1999. The
keys for this figure are retained in the structure–function analysis
presentation in Figure 4.
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Figure 4. (A) Vulval differentiation in germline-transformed progeny carrying various minigene constructs, as indicated. Vulval differentiation is
scored in L4 non-Dpy progeny after heat shock in early L3 (genotype let-23(sy1); dpy-20; sli-1; syEx[heat shock construct 1 pMH86(dpy-201)]). The
first column contains schematic representations of the mutant constructs inserted into the heat-shock minigene pPD49.83. The second column lists
construct designations. Average number of VPCs that undergo vulval differentiation are calculated in the third column for each independent stable
line. The results are averaged from the combined data of column 3 in column 4. (B) Histograms. The distribution of vulval differentiation levels of
the combined data (column 4, panel A) obtained using the various heat-shock minigene constructs described in panel A. The horizontal scale (1–6)
represents the number of VPCs that became vulval tissue per worm, scored in half-cell increments. Vertical scale (0–100%) represents the percentage
of total worms scored with a given level of vulval differentiation. The constructs are listed directly below each histogram, and the names correspond
to the construct designations of panel A.
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a stretch of ;50 N-terminal residues in the two proteins
(Figure 3). This region contains the SH2 and RING finger
domains strongly implicated in Cbl function (Joazeiro et al.,
1999; Levkowitz et al., 1999). The N-terminal 45 and 58
residues of c-Cbl and SLI-1, respectively, are highly diver-
gent in sequence. Furthermore, although both proteins have
several putative SH3-binding polyproline motifs in their
respective C-terminal domains, the amino acid sequence
after residue 447 in SLI-1 and residue 437 in c-Cbl are also
largely divergent.
To test for the functional similarity between the conserved
domains of SLI-1 and c-Cbl, we constructed a chimeric sli-
1/c-cbl cDNA by replacing the coding sequence of SLI-19s
N-terminal region and RING finger domain (residues 58–
447) with that of c-Cbl (residues 45–437). We find that this
c-Cbl/SLI-1 chimeric construct driven by the hsp16–41 pro-
moter exhibits partial SLI-1(1) activity (1.5 vulval cells per
worm; p , 0.0001 versus both the no-insert control and the
full-length sli-1 cDNA; Figure 4, A and B). As a control, a
sli-1 construct lacking the N-terminal region and RING fin-
ger domain (deleting residues 58–447) was tested. It was
shown not to have SLI-1(1) activity under identical assay
conditions (i.e., vulval induction levels similar to the no-
insert control; p 5 0.8; Figure 4, A and B). However, the
full-length c-Cbl cDNA driven by the hsp16–41 promoter
does not have SLI-1(1) activity in the vulva (our unpub-
lished results).
A SLI-1 Protein Lacking the RING Finger Domain
Retains Some Activity
Both sli-1 and c-Cbl function as negative regulators of sig-
naling. c-Cbl recently has been shown to have a ubiquitin
ligase activity that is proposed to explain the negative reg-
ulation of RTKs signaling observed (Joazeiro et al., 1999;
Levkowitz et al., 1999). Thus, the SH2 domain presumably
mediates binding to the activated receptor, and the RING
finger domain then catalyzes receptor ubiquitination. The
SH2 and RING finger domains of c-Cbl share 55% identity
with those of SLI-1 and can functionally replace them in our
transgenic assay. We sought to test whether the RING finger
domain of SLI-1 was essential for activity. We found that
significant SLI-1(1) activity is observed in constructs lacking
the RING finger (average, 1.5 vulval cells per worm; p ,
0.0001 versus no-insert control; Figure 4, A and B). However,
in comparison with the full-length cDNA, the RING deletion
significantly reduces the SLI-1(1) activity (p , 0.0001).
Thus, although the RING finger domain is important for
SLI-1 activity, a ubiquitin ligase function for SLI-1 is not the
sole inhibitory function of sli-1.
pYKTEP Defines an Inhibitory Site in the C-terminal
Tail of LET-23, Mediating the Negative Effect of
SLI-1
We next explored the possibility that SLI-1 exerts its inhib-
itory effect by direct or indirect binding to specific pTyr sites
in LET-23. The let-23(sy97) mutation deletes the last 56
amino acids of the receptor, which include the only three
tyrosines (pTyr sites 6, 7, and 8) in the receptor carboxy-
terminal tail, which, if phosphorylated, would create SH2
binding sites matching the consensus binding site for the
SEM-5 SH2 domain. sli-1(lf) strongly suppresses let-23(sy97),
which suggests that pTyr site 1 through pTyr site 5 could
mediate, directly or indirectly, negative regulation of let-23
signaling by sli-1 under the above hypothesis. We intro-
duced engineered let-23 constructs, with certain codons
specifying LET-23 carboxy-terminal tyrosine residues mu-
tated to phenylalanine codons, into nematodes with a let-
23(null) background with or without a sli-1 or ark-1 mutation
and assayed their activity by scoring transgenic animals for
vulval differentiation. Our results suggest that SLI-1 func-
tion is dependent on LET-23 carboxy-terminal tyrosine res-
idues. Particularly, we observed that the inhibition of sig-
naling by the presence of pTyr2 could be overcome by
mutations in sli-1 (Table 2). We therefore sought to deter-
mine whether the absence of this site would synergize with
mutations in genes known to negatively regulate let-23 sig-
naling. We did not observe any synergy between let-23(null);
syEx[LET-23 (Y22)] and sli-1. However, we observed that
let-23(null); syEx[LET-23 (Y22)] did synergize with ark-1,
resulting in 34% of animals having greater than wild-type
levels of vulval induction (Table 2). This synergy was not
observed in ark-1 animals overexpressing an intact LET-23
construct (Table 2). ark-1 was isolated as an enhancer of sli-1
and encodes a non-RTK related to Ack that inhibits LET-23
signaling (Hopper et al., 2000). Forty percent of ark-1; sli-1
double-mutant animals have a hyperinduced vulval pheno-
type, with the extra induction usually being in P4.p (Table
3). This phenotype is distinct from ark-1; gap-1 double-mu-
tant animals, which have a higher penetrance of extra in-
duction, usually as a consequence of P8.p induction (Table
3). It is striking that the hyperinduced vulval phenotype of
Table 2. pTyr site 2 in the carboxyl-terminal tail of LET-23 mediates
negative regulation of LET-23 signaling by SLI-1a
Average vulval induction (%)b
C-terminus ark-1(1); sli-1(1)c sli-1(2) ark-1(2)
1 2 3 4 5 6 7 8 99 (n 5 22) 91 (n 5 63)d
– – – – – – – – 4 (n 5 42)
– 2 – – – – – – z z ze z z ze
– – 3 – – – – – 3 (n 5 11) 8 (n 5 28)
– – – 4 – – – – 93 (n 5 42) 94 (n 5 8)
– – – – 5 – – – 11 (n 5 53) 21 (n 5 22)
– – – – – 6 – – 100 (n 5 65) 89 (n 5 67)
– 2 – 4 – – – – 42 (n 5 85) 86 (n 5 47) 48 (n 5 76)
1 – 3 4 5 6 7 8 99 (n 5 26) 82 (n 5 41) 107 (n 5 32)f
a Carboxyl-terminal sites 1, 2, 3, etc., indicate that tyrosine(s) at that
putative SH2-binding sites have not been changed; a dash indicates
that each tyrosine in the corresponding site has been substituted
with phenylalanine. At least two stable lines were analyzed per
construct, except for the site 3 construct, which has only one stable
line analyzed.
b Average percentage of vulval precursor cells adopting vulval fates
per animal.
c Taken from Lesa and Sternberg (1997).
d One animal of 63 had greater than three cells induced (3.5-cell
induction).
e The presence of site 2 in the absence of other carboxyl-terminal
sites confers animals inviability in the genetic backgrounds of let-
23(lf). sli-1(lf) weakly suppresses this lethality.
f Thirty-four percent of scored animals are Muv.
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let-23(null); ark-1; syEx[LET-23 (Y22)] is nearly identical to
that seen in ark-1; sli-1 animals, both in penetrance and
frequency of P4.p induction versus P8.p induction (Table
3).Together, this led us to conclude that pTyr 2 (pYKTEP)
mediates its effects through sli-1. This conclusion is strength-
ened by a recently solved crystallographic structure of c-Cbl
complexed to a tyrosine-phosphorylated inhibitory site of
protein tyrosine kinase ZAP-70 (Meng et al., 1999). The in-
teraction is mediated by a divergent SH2 domain of c-Cbl,
which is conserved in SLI-1, and a pTyr of ZAP-70, which is
in a similar amino acid context to the one in LET-23 that we
identified (pYXXEP versus pYKTEP; XX represents pY11
and pY12 residues, which are not in the interface of the
binding complex).
DISCUSSION
The sli-1 locus was originally defined by mutations that
suppress partially defective LET-23, a C. elegans homologue
of EGF-receptor subfamily tyrosine kinases (Jongeward et
al., 1995). The overall sequence of SLI-1 resembles that of the
mammalian proto-oncoprotein c-Cbl and related proteins
(Cbl-b and Cbl-3). In this study, we have found the follow-
ing: (1) mutations in SLI-1 suppress rf mutations in SEM-5
but not LET-60 RAS, which are mutations that likely inter-
fere with exchange factor interaction; (2) mutations in SLI-1
do not bypass the requirement for SEM-5, and a sem-5 null
allele is not suppressed by sli-1; (3) the SLI-1 N-terminal
region and RING finger domain is sufficient to confer partial
wild-type SLI-1 activity in the vulva; (4) the conserved N-
terminal region and RING finger domain in c-Cbl can sub-
stitute for those of SLI-1 such that a chimeric protein can
negatively regulate vulval differentiation; and (5) the ubiq-
uitin ligase domain of SLI-1 is not absolutely required for
negative regulation by SLI-1.
Our genetic analyses led us to believe that SLI-1 inhibits
signaling between LET-23 and RAS for the following rea-
sons. The reduced activity of SLI-1 can increase vulval sig-
naling in a sem-5(rf) background: sli-1, the reference allele,
strongly suppresses the vulvaless phenotype of non-null
sem-5 rf alleles (Jongeward et al., 1995; this study). However,
we also have shown that sli-1 does not suppress a sem-5 null
allele. Thus, SEM-5 activity is essential for RTK-mediated
vulval signaling with or without the presence of wild-type
SLI-1. We conclude that SLI-1 is a negative regulator of
SEM-5-dependent signaling after LET-23 activation. In con-
trast, severe reduction of LET-60 Ras activity is not compen-
sated for by the absence of SLI-1. We thus infer that SLI-1
affects vulval signaling upstream of LET-60 Ras. Further-
more, the Muv phenotype of sli-1 gap-1 double-mutant ani-
mals indicates that SLI-1 and GAP-1 define, at least partly,
independent pathways. Recently, another GAP gene, gap-2,
has been identified in C. elegans (Hayashizaki et al., 1998);
however, mutations of gap-2 do not suppress the vulvaless
phenotype of let-23 mutations (Hayashizaki et al., 1998); (C.
Chang, unpublished observations). gap-1 and gap-2 are the
only RasGAPs found in C. elegans by genome-wide blast
search.
Results from our SLI-1/c-Cbl chimeric construct indicate
that the N-terminal region and RING finger domains of
SLI-1 and c-Cbl are functionally conserved with respect to
vulval signaling. Our structure–function studies show that
the conserved N-terminal region and RING finger domain of
SLI-1 are necessary and almost sufficient for negative regu-
latory activity in LET-23-mediated signal transduction. That
the N-terminal region and RING finger domain may have a
conserved regulatory function in RTK signaling is supported
by two lines of evidence from elsewhere. First, identification
of a Drosophila c-cbl homologue (Drosophila-Cbl; or D-cbl)
revealed that the D-Cbl product shares the conserved N-
terminal domain with c-Cbl and SLI-1 (Hime et al., 1997;
Meisner et al., 1997). As in the alignment of SLI-1 and c-Cbl,
the sequence similarity of D-Cbl begins after a stretch of
divergent N-terminal residues that are different from both
c-Cbl and SLI-1. However, unlike SLI-1 and c-Cbl, the D-Cbl
sequence ends shortly C-terminal to the RING finger motif
and contains no polyproline motifs. As expected from the
lack of poly-proline motifs, D-Cbl does not bind Drk, the
Drosophila homologue of SEM-5/Grb2 adaptor (Hime et al.,
1997; Meisner et al., 1997). Furthermore, both reports show
that D-Cbl associates with the Drosophila EGFR in an activa-
tion-dependent manner. Finally, Meisner et al. (1997) show
that the expression of D-cbl under the sevenless enhancer in
Drosophila negatively regulates R7 photoreceptor develop-
ment. These results suggest that the conserved N-terminal
domains of SLI-1 and D-Cbl play analogous roles and that
these domains are sufficient for the negative regulation of
the LET-23 and Drosophila sevenless pathways. Second, it was
previously shown that introduction of a hypomorphic Gly-
to-Glu missense mutation found in SLI-19s N-terminal do-
main (Yoon et al., 1995) can abolish c-Cbl binding to ZAP-70
and EGFR and can ablate the transforming function of v-Cbl
(Lupher et al., 1996; Thien and Langdon, 1997). Thus, iden-
tical mutations in a conserved residue in the N-terminal
domains disrupts function in both SLI-1 and c-Cbl, suggest-
ing structural and functional conservation.
Table 3. Frequency of induction of the Pn.p cells in different mutantsa
Mutants
Frequency of being induced (%)
Average
induction nP3.p P4.p P5.p P6.p P7.p P8.p
ark-1; sli-1 1.3 26.3 100 100 100 6.3 3.35 40
ark-1; gap-1 5 15 100 100 100 80 4.0 20
ark-1; Y22 3.2 25.8 100 100 100 5.6 3.35 62
Animals scored at 20°C. ark-1; Y22 animals actual genotype is let-23(null) unc-4; dpy-20 ark-1; syEx[dpy-20(1); let-23(Y22)]. Only those animals
with greater or equal to three cells induced scored for ark-1; Y22. Data were pooled from three independent lines.
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It is unclear why the full-length c-Cbl construct does not
have SLI-1(1) function in our assays despite the fact that the
conserved N-terminal domain of c-Cbl can functionally re-
place the corresponding domain in SLI-1 in a chimeric con-
struct. Several explanations are possible. One reason may be
that the size of the C-terminal domain of c-Cbl prevents
sterically an effective association with the cytoplasmic por-
tion of the LET-23 protein; the C-terminal domain of c-Cbl is
three times the mass of that of SLI-1. Or, the nematode
translational machinery does not properly recognize the
initiator methionine of c-Cbl, therefore preventing effective
expression. A third possibility is that the highly divergent
stretch of residues N-terminal to the conserved domains
could serve important species–specific functions.
The C-terminal polyproline motifs, although not essential
for SLI-1 function, are necessary for the full wild-type neg-
ative regulatory activity; the SLI-1:N1RING finger protein is
significantly less effective than the full-length SLI-1 (39% Vul
for the SLI-1:N1RING finger protein versus 74% Vul for
full-length SLI-1; Figure 4B; p 5 0.0002). This effect may
simply be caused by a reduction in protein stability due to
early truncation. However, we have found that the polypro-
line-rich C-terminus of SLI-1 can interact with SEM-5 in a
yeast 2 hybrid assay (this study; Walhout et al., 2000). This
raises another possibility for the function of the C-terminal
polyproline motifs: SEM-5, or a similar adaptor, may bind to
SLI-1 and increase the efficacy of SLI-1 localization to the
RTK complex, due to the binding of the adaptor to the
receptor pTyr sites. In mammalian cells, the C-terminal
polyproline domains of c-Cbl have been shown to bind
adaptors such as Grb2 and Nck via PPII helix-SH3 interac-
tions (Rivero-Lezcano et al., 1994; Meisner and Czech, 1995;
Donovan et al., 1996; Clements et al., 1999). Furthermore, it
has been shown that Grb2 can mediate an indirect associa-
tion between c-Cbl and EGFR (Meisner and Czech, 1995). In
a similar manner, the C-terminal polyproline domains of
SLI-1 may bind to SH3 domains of adaptor proteins, which
in turn enhance the localization of the N-terminal domain of
SLI-1 to the activated LET-23 receptor. In addition, it is also
possible that the polyproline domains of SLI-1 may compete
with the polyproline domains of Sos in binding SEM-5,
thereby enhancing the inhibition of the LET-23 RTK path-
way by SLI-1.
The RING finger domain of c-Cbl has been shown recently
to enhance ubiquitination of active RTKs by acting as an E3
ubiquitin–protein ligase (Levkowitz et al., 1998; Joazeiro et
al., 1999; Levkowitz et al., 1999). Thus, the effects of the loss
of sli-1 activity might be explained by the failure of the
LET-23 RTK to be down-regulated by a ubiquitination-de-
pendent degradation pathway. However, we find that the
RING finger domain of SLI-1 is partially dispensable: an
SLI-1 variant lacking its RING finger domain retains a sig-
nificant amount of biological activity. Thus, the ubiquitin–
ligase activity of SLI-1/c-Cbl is unlikely to be the sole activ-
ity of SLI-1. This conclusion is strengthened by other
findings. It might be expected that if the sole function of
SLI-1 was to target-activated receptor for degradation so
that (1) there might be more LET-23 observable in a sli-1(lf)
background, and (2) that over expression of LET-23 might
mimic sli-1(lf). Neither of these effects has been observed
(Table 2).
In summary, we find that SLI-1 inhibits LET-60 RAS acti-
vation by LET-23. We suggest that SLI-1 interacts with the
LET-23 signaling complex via at least two domains. One of
these domains, the proline-rich C-terminal portion, is neces-
sary for the wild-type level of activity of SLI-1 in the context
of a full-length protein; its role is likely to interact with an
SH3 domain-containing protein. SEM-5 is a candidate due to
the interaction between SLI-1 and SEM-5 that we observed
in our yeast two-hybrid assays. Since the C-terminal proline-
rich domain alone is not sufficient to inhibit signaling, we
infer that SLI-1 does not simply titrate SEM-5 from the
RTK/Ras pathway. In addition, an SLI-1 protein lacking this
proline-rich C-terminal portion retains inhibitory function
on signaling. Thus, the remaining N terminal and RING
finger domains must be able to interact with some of the
components of the signaling complex directly by a different
mechanism. In mammalian cell lines, the conserved N-ter-
minal domain of c-Cbl associates directly with the autophos-
phorylated C-terminal region of the EGFR (Bowtell and
Langdon, 1995; Galisteo et al., 1995; Lupher et al., 1997). The
N-terminal domain also has been shown to associate with
the non-RTK ZAP-70 in a phosphorylation-dependent man-
ner in T cells (Lupher et al., 1996). In both cases, the associ-
ation requires the N-terminal divergent SH2 domain and not
the C-terminal polyproline motifs. We explored the possi-
bility that SLI-1 may exert its inhibitory effect by direct or
indirect binding to specific pTyr sites in LET-23. By analyz-
ing the systematically mutagenized let-23 constructs con-
taining substitutions in the carboxyl-terminal tyrosine resi-
dues, we have identified an inhibitory tyrosine residue that
can overcome the negative regulation by sli-1 when it is
mutated. Our current models for sli-1 functions propose two
roles (Figure 1). The major role of sli-1 might be to attenuate
signaling after activation has occurred. On induction, SLI-1
is recruited into the receptor-signaling complex by itself or
an adaptor protein, and negative regulation ensues by some
other means, possibly by preventing the association and
activation of downstream effectors such as the SEM-5 adap-
tor and/or LET-341 SOS-1, via catalyzing the ubiquitination
of the receptor, thus targeting it for degradation. The minor
role of sli-1 might be to regulate the basal activity of signal-
ing in a quiescent state by competing with LET-341 SOS-1
for the binding of SEM-5, thereby decreasing the chance that
the spontaneously activated receptor recruits the SOS-1-
bound SEM-5 in the absence of ligand. Other models are
possible, since we cannot rule out the possible existence of
uncharacterized catalytic domains in SLI-1.
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